FDA approves new vaccine for smallpox

Share this article:

The FDA has approved a new vaccine against smallpox which could be quickly made if the virtually extinct virus were to reappear.

The vaccine, ACAM2000 is made by Acambis of Cambridge, England and Cambridge, MA. It is intended to inoculate those at high risk of exposure to smallpox and could be used to protect individuals and populations during a bioterrorist attack. 

The federal Centers for Disease Control and Prevention has already stockpiled 192.5 million doses of the vaccine.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.